Finance

Lists
Why is 4588 down 3,24%?
Dive Deeper
4588:TYO
Oncolys Biopharma Inc
5 970,00 JP¥
-3,24%
(-200,00) 1D
9 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4588...
Open
6 150 JP¥
High
6 390 JP¥
Low
5 760 JP¥
Mkt. cap
176,18 млрд
Avg. vol.
1,91 млн
Volume
1,10 млн
52-wk high
7 020 JP¥
52-wk low
668 JP¥
EPS
-54 JP¥
Shares outstanding
13,14 млн
No. of employees
45
Open
6 150 JP¥
High
6 390 JP¥
Low
5 760 JP¥
Mkt. cap
176,18 млрд
Avg. vol.
1,91 млн
Volume
1,10 млн
52-wk high
7 020 JP¥
52-wk low
668 JP¥
EPS
-54 JP¥
Shares outstanding
13,14 млн
No. of employees
45
News stories
From web sources and news partners
About Oncolys Biopharma Inc
CEO-
Employees45
Founded2004 ж. 18 нау.
Headquarters-
Sector-
Websiteoncolys.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. мау.
2025 ж. қыр.
2026 ж. нау.
2026 ж. мау.
Revenue
28,55 млн
-
3,09 млн
500,00 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
510,47 млн
303,94 млн
423,81 млн
846,89 млн
Operating expense
511,47 млн
305,01 млн
423,81 млн
849,46 млн
Total operating expenses
511,47 млн
305,01 млн
423,81 млн
849,46 млн
Operating income
-482,92 млн
-305,01 млн
-420,72 млн
-349,46 млн
Other non operating income
13,00 мың
-8,69 млн
-2,14 млн
-62,00 мың
EBT including unusual items
-500,86 млн
-302,92 млн
-413,36 млн
-347,24 млн
EBT excluding unusual items
-500,86 млн
-302,92 млн
-413,36 млн
-347,24 млн
Income tax expense
713,00 м.
891,00 м.
1,12 млн
430,00 м.
Effective tax rate
-0,14%
-0,29%
-0,27%
-0,12%
Other operating expenses
-
-
-
-
Net income
-501,58 млн
-303,81 млн
-414,48 млн
-347,67 млн
Net profit margin
-1 757,08%
-
-13 413,66%
-69,53%
Earnings per share
-
-
-
-
Interest and investment income
479,00 м.
1,52 млн
3,04 млн
199,00 м.
Interest expense
-1,20 млн
-1,51 млн
-2,99 млн
-5,85 млн
Net interest expenses
-725,00 м.
10,00 мың
58,00 мың
-5,65 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-482,90 млн
-304,80 млн
-420,71 млн
-349,42 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары